Article
Network pharmacology analysis of ZiShenWan for diabetic nephropathy and experimental verification of its anti-inflammatory mechanism
2020-12-15
Abstract excerpt
<h4>Background: </h4> Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The inflammatory response plays a critical role in the process of DN. ZiShenWan (ZSW) is a classical Chinese medicinal formula with remarkable clinical therapeutic effects on DN, but its pharmacological action mechanisms remain unclear. <h4>Methods:</h4> In this study, a network pharmacology approach was applied...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a4f22a11-acc6-501f-a3cd-718e566015ae
- DOI
- 10.21203/rs.3.rs-127749/v1
